April 2, 2025
ÎçÒ¹¾ç³¡ School of Medicine
ÎçÒ¹¾ç³¡ Hospital
National Hospital Organization Osaka National Hospital
National Hospital Organization Murayama Medical Center
ÎçÒ¹¾ç³¡ Hospital has completed the scheduled follow-up observations and data collection for all four cases in its clinical study on regenerative medicine using iPS cell-derived neural stem/progenitor cells to treat subacute spinal cord injuries.
Moving forward, we will promptly submit a comprehensive report and summary to the Minister of Health, Labour and Welfare in accordance with the Act on Securing Safety of Regenerative Medicine and related regulations.
For further information, please refer to the following PDF file.